Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo

Tumor microenvironments can promote stem cell maintenance, tumor growth, and therapeutic resistance, findings linked by the tumor-initiating cell hypothesis. Standard of care for glioblastoma (GBM) includes temozolomide chemotherapy, which is not curative, due, in part, to residual therapy-resistant...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:JCI Insight
Huvudupphovsmän: Boyd, Nathaniel H., Walker, Kiera, Fried, Joshua, Hackney, James R., McDonald, Paul C., Benavides, Gloria A., Spina, Raffaella, Audia, Alessandra, Scott, Sarah E., Landis, Catherine J., Tran, Anh Nhat, Bevensee, Mark O., Griguer, Corinne, Nozell, Susan, Gillespie, G. Yancey, Nabors, Burt, Bhat, Krishna P., Bar, Eli E., Darley-Usmar, Victor, Xu, Bo, Gordon, Emily, Cooper, Sara J., Dedhar, Shoukat, Hjelmeland, Anita B.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Clinical Investigation 2017
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5752277/
https://ncbi.nlm.nih.gov/pubmed/29263302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.92928
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk